These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27300339)

  • 1. Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
    May M; Fritsche HM; Vetterlein MW; Bastian PJ; Gierth M; Nuhn P; Aziz A; Fisch M; Stief CG; Hohenfellner M; Wirth MP; Novotny V; Hakenberg OW; Noldus J; Gilfrich C; Bolenz C; Burger M; Brookman-May SD;
    World J Urol; 2017 Feb; 35(2):245-250. PubMed ID: 27300339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
    Cai T; Tiscione D; Verze P; Pomara G; Racioppi M; Nesi G; Barbareschi M; Brausi M; Gacci M; Luciani LG; Liguori G; Gontero P; Campodonico F; Simonato A; Boddi V; Di Stasi SM; Colombo R; Serretta V; Carmignani G; Malossini G; Altieri V; Carini M; Terrone C; Bassi P; Montorsi F; Ficarra V; Selli C; Mirone V; Bartoletti R
    Urology; 2014 Nov; 84(5):1141-6. PubMed ID: 25239253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
    Gakis G; Ngamsri T; Rausch S; Mischinger J; Todenhöfer T; Schwentner C; Schmid MA; Hassan FA; Renninger M; Stenzl A
    World J Urol; 2015 Oct; 33(10):1429-37. PubMed ID: 25595732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
    Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy.
    Renninger M; Fahmy O; Schubert T; Schmid MA; Hassan F; Stenzl A; Gakis G
    World J Urol; 2020 Feb; 38(2):397-406. PubMed ID: 31030231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
    Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.
    Zamboni S; Moschini M; Gallina A; Colombo R; Montorsi F; Briganti A; Salonia A; Antonelli A; Simeone C; Belotti S; Cristinelli L; Mattei A; Baumeister P
    World J Urol; 2019 Dec; 37(12):2707-2714. PubMed ID: 30911811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients.
    Rehme C; Fritsch B; Thomas L; Istin S; Burchert C; Hummel B; Baleanu-Curaj B; Reis H; Szarvas T; Ruebben H; Hadaschik B; Niedworok C
    Int Urol Nephrol; 2022 Jan; 54(1):71-79. PubMed ID: 34817753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Pak JS; Haas CR; Anderson CB; DeCastro GJ; Benson MC; McKiernan JM
    Urol Oncol; 2021 Nov; 39(11):787.e9-787.e15. PubMed ID: 33865688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
    May M; Protzel C; Vetterlein MW; Gierth M; Noldus J; Karl A; Grimm T; Wullich B; Grimm MO; Nuhn P; Bastian PJ; Roigas J; Hadaschik B; Gilfrich C; Burger M; Fisch M; Brookman-May S; Aziz A; Hakenberg OW;
    Int Urol Nephrol; 2017 Feb; 49(2):247-254. PubMed ID: 27896578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
    Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer?
    Schmid M; Rink M; Traumann M; Bastian PJ; Bartsch G; Ellinger J; Grimm MO; Hadaschik B; Haferkamp A; Hakenberg OW; Aziz A; Hartmann F; Herrmann E; Hohenfellner M; Janetschek G; Gierth M; Pahernik Sh; Protzel C; Roigas J; Gördük M; Lusuardi L; May M; Trinh QD; Fisch M; Chun FK;
    Ann Surg Oncol; 2015 Mar; 22(3):1032-42. PubMed ID: 25164037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer?
    Chen CL; Liu CY; Cha TL; Hsu CY; Chou YC; Wu ST; Meng E; Sun GH; Yu DS; Tsao CW
    J Chin Med Assoc; 2015 Aug; 78(8):469-74. PubMed ID: 26074367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
    Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG
    Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
    Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
    Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
    Hirasawa Y; Nakashima J; Yunaiyama D; Sugihara T; Gondo T; Nakagami Y; Horiguchi Y; Ohno Y; Namiki K; Ohori M; Tokuuye K; Tachibana M
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1048-1054. PubMed ID: 27699608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Real-life experience': recurrence rate at 3 years with Hexvix
    Gallagher KM; Gray K; Anderson CH; Lee H; Stewart S; Donat R; Mariappan P
    World J Urol; 2017 Dec; 35(12):1871-1877. PubMed ID: 28803385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer.
    May M; Burger M; Brookman-May S; Stief CG; Fritsche HM; Roigas J; Zacharias M; Bader M; Mandel P; Gilfrich C; Seitz M; Tilki D
    Clin Genitourin Cancer; 2014 Aug; 12(4):278-86. PubMed ID: 24331576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.